Elanco

Elanco Animal Health Incorporated
Company typePublic
IndustryPharmaceutical (animal)
Founded1954 
HeadquartersGreenfield, Indiana, U.S.
Key people
  • R. David Hoover (Chairman)
  • Jeff Simmons (CEO)
ProductsPharmaceutical drugs (animal)
Revenue US$4.765 billion (2021)
US$0.567 billion (2021)
US$0.472 billion (2021)
Total assets US$16.483 billion (2021)
Total equity US$7.538 billion (2021)
Number of employees
10,200 (2021)
Websiteelanco.com

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.